ALKS FY 2011 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$390M+108.9% YoY

Gross Profit

$262M67.3% margin

Operating Income

-$88M-22.6% margin

Net Income

-$114M-29.1% margin

EPS (Diluted)

$-0.99

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$15M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$601M

Stockholders' Equity

$905M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$390M	$187M	+108.9%
Gross Profit	$262M	$134M	+95.2%
Operating Income	-$88M	-$46M	-93.5%
Net Income	-$114M	-$46M	-149.6%